financetom
Business
financetom
/
Business
/
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing
Jun 17, 2024 1:36 PM

04:05 PM EDT, 06/17/2024 (MT Newswires) -- Michael S Brown, Director, on June 14, 2024, sold 1,535 shares in Regeneron Pharmaceuticals ( REGN ) for $1,596,400. Following the Form 4 filing with the SEC, Brown has control over a total of 12,544 shares of the company, with 1,382 shares held directly and 11,162 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/872589/000196820224000102/xslF345X03/edgardoc.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved